The Potential and Current Progress of Internalizing Molecules in Targeted Drug Delivery - Intracellular Delivery: Fundamentals and Applications - page 115

Alam, M. R., Ming, X., Dixit, V., Fisher, M., Chen, X. & Juliano, R. L. (2010) The biological
effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking.
Oligonucleotides , 20, 103-9.
Allen, T. M. (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer , 2,
750-63.
Bagalkot, V., Farokhzad, O. C., Langer, R. & Jon, S. (2006) An aptamer-doxorubicin physical
conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl , 45, 8149-52.
Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R. & Farokhzad,
O. C. (2007) Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and
sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett ,
7, 3065-70.
Banerjee, R., Tyagi, P., Li, S. & Huang, L. (2004) Anisamide-targeted stealth liposomes: a potent
carrier for targeting doxorubicin to human prostate cancer cells. Int J Cancer , 112, 693-700.
Bartlett, D. W. & Davis, M. E. (2007) Physicochemical and biological characterization of targeted,
nucleic acid-containing nanoparticles. Bioconjug Chem , 18, 456-68.
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A. & Davis, M. E. (2007) Impact of tumor-
specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by
multimodality in vivo imaging. Proc Natl Acad Sci U S A , 104, 15549-54.
Bates, P. J., Kahlon, J. B., Thomas, S. D., Trent, J. O. & Miller, D. M. (1999) Antiproliferative
activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem , 274,
26369-77.
Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D.,
Weigert, R., Gutkind, J. S. & Rusling, J. F. (2009) Targeted killing of cancer cells in vivo and
in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano , 3, 307-16.
Boraston, A. B., Bolam, D. N., Gilbert, H. J. & Davies, G. J. (2004) Carbohydrate-binding mod-
ules: fine-tuning polysaccharide recognition. Biochem J , 382, 769-81.
Bremer, E., Samplonius, D. F., Peipp, M., van Genne, L., Kroesen, B. J., Fey, G. H., Gramatzki,
M., de Leij, L. F. & Helfrich, W. (2005) Target cell-restricted apoptosis induction of acute
leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand
fusion protein with specificity for human CD7. Cancer Res , 65, 3380-8.
Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G. C., Cheng, J. & Lu, Y. (2009) Reversible cell-
specific drug delivery with aptamer-functionalized liposomes. Angew Chem Int Ed Engl ,
48, 6494-8.
Chang, J., Jallouli, Y., Kroubi, M., Yuan, X. B., Feng, W., Kang, C. S., Pu, P. Y. & Betbeder, D.
(2009) Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the
blood-brain barrier. Int J Pharm , 379, 285-92.
Chen, C. H., Dellamaggiore, K. R., Ouellette, C. P., Sedano, C. D., Lizadjohry, M., Chernis,
G. A., Gonzales, M., Baltasar, F. E., Fan, A. L., Myerowitz, R. & Neufeld, E. F. (2008) Aptamer-
based endocytosis of a lysosomal enzyme. Proc Natl Acad Sci U S A , 105, 15908-13.
Cheresh, D. A. (1987) Human endothelial cells synthesize and express an Arg-Gly-Asp-directed
adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl
Acad Sci U S A , 84, 6471-5.
Chiu, S. J., Ueno, N. T. & Lee, R. J. (2004a) Tumor-targeted gene delivery via anti-HER2 anti-
body (trastuzumab, Herceptin) conjugated polyethylenimine. J Control Release , 97, 357-69.
Chiu, Y. L., Ali, A., Chu, C. Y., Cao, H. & Rana, T. M. (2004b) Visualizing a correlation between
siRNA localization, cellular uptake, and RNAi in living cells. Chem Biol , 11, 1165-75.
Cho, K. C., Kim, S. H., Jeong, J. H. & Park, T. G. (2005) Folate receptor-mediated gene delivery
using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. Macromol Biosci , 5, 512-9.
Chu, T. C., Marks, J. W., 3 rd, Lavery, L. A., Faulkner, S., Rosenblum, M. G., Ellington, A. D. &
Levy, M. (2006a) Aptamer: toxin conjugates that specifically target prostate tumor cells.
Cancer Res , 66, 5989-92.
Chu, T. C., Twu, K. Y., Ellington, A. D. & Levy, M. (2006b) Aptamer mediated siRNA delivery.
Nucleic Acids Res , 34, e73.